On the public citation graph

Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic

https://doi.org/10.3390/life12091384

0 signed · 154 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

2 of the 141 references listed on this page are in the Retraction Watch database as retracted (export 2026-10-28): 10.1016/j.heliyon.2021.e07311 (notice 2025-02-07), 10.21203/rs.3.rs-100956/v3 (notice 2020-12-28).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2021.3071openalex-snapshot

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19

inferredcites →https://doi.org/10.1002/14651858.cd015017.pub2openalex-snapshot

Ivermectin for preventing and treating COVID-19

inferredcites →https://doi.org/10.1002/14651858.cd015017.pub3openalex-snapshot

Ivermectin for preventing and treating COVID-19

inferredcites →https://doi.org/10.1002/cpt.1889openalex-snapshot

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19

inferredcites →https://doi.org/10.1002/iub.2356openalex-snapshot

Bacterial co‐infections with SARS‐CoV ‐2

inferredcites →https://doi.org/10.1002/jcb.27420openalex-snapshot

Ivermectin inhibits the growth of glioma cells by inducing cell cycle arrest and apoptosis in vitro and in vivo

inferredcites →https://doi.org/10.1002/jcb.27490openalex-snapshot

Suppressing ROS‐TFE3‐dependent autophagy enhances ivermectin‐induced apoptosis in human melanoma cells

inferredcites →https://doi.org/10.1002/jcp.30055openalex-snapshot

Quantitative proteomics reveals a broad‐spectrum antiviral property of ivermectin, benefiting for COVID‐19 treatment

inferredcites →https://doi.org/10.1002/jmv.25987openalex-snapshot

In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs

inferredcites →https://doi.org/10.1002/jmv.26387openalex-snapshot

Targeting human TLRs to combat COVID‐19: A solution?

inferredcites →https://doi.org/10.1002/jmv.26776openalex-snapshot

In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans

inferredcites →https://doi.org/10.1002/jmv.26880openalex-snapshot

Effect of a combination of nitazoxanide, ribavirin, and ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID‐19

inferredcites →https://doi.org/10.1002/jmv.27324openalex-snapshot

Atypical bacterial co‐infections among patients with COVID‐19: A study from India

inferredcites →https://doi.org/10.1002/path.1570openalex-snapshot

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

inferredcites →https://doi.org/10.1002/prot.26164openalex-snapshot

Repurposing of FDA ‐approved drugs against active site and potential allosteric drug‐binding sites of COVID ‐19 main protease

inferredcites →https://doi.org/10.1002/prp2.954openalex-snapshot

RETRACTED: Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways

inferredcites →https://doi.org/10.1002/tox.23440openalex-snapshot

Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK / STAT signaling pathway activation

inferredcites →https://doi.org/10.1007/978-1-4939-2438-7_1openalex-snapshot

Coronaviruses: An Overview of Their Replication and Pathogenesis

inferredcites →https://doi.org/10.1007/s00011-008-8007-8openalex-snapshot

Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice

inferredcites →https://doi.org/10.1007/s00011-011-0307-8openalex-snapshot

Anti-inflammatory effects of ivermectin in mouse model of allergic asthma

inferredcites →https://doi.org/10.1007/s00280-020-04041-zopenalex-snapshot

Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug

inferredcites →https://doi.org/10.1007/s11684-020-0754-0openalex-snapshot

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

inferredcites →https://doi.org/10.1007/s12272-021-01331-9openalex-snapshot

COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development

inferredcites →https://doi.org/10.1007/s13555-018-0249-yopenalex-snapshot

Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations

inferredcites →https://doi.org/10.1007/s15010-020-01553-xopenalex-snapshot

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

inferredcites →https://doi.org/10.1007/s15010-021-01602-zopenalex-snapshot

State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia

inferredcites →https://doi.org/10.1007/s40264-021-01066-yopenalex-snapshot

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

inferredcites →https://doi.org/10.1016/b978-0-7295-3929-6.50068-9openalex-snapshot

10.1016/b978-0-7295-3929-6.50068-9

inferredcites →https://doi.org/10.1016/j.antiviral.2018.09.010openalex-snapshot

Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo

inferredcites →https://doi.org/10.1016/j.antiviral.2020.104760openalex-snapshot

The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer

inferredcites →https://doi.org/10.1016/j.antiviral.2020.104787openalex-snapshot

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

inferredcites →https://doi.org/10.1016/j.bbadis.2021.166294openalex-snapshot

Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication

inferredcites →https://doi.org/10.1016/j.bbrc.2016.10.064openalex-snapshot

Anthelmintic drug ivermectin inhibits angiogenesis, growth and survival of glioblastoma through inducing mitochondrial dysfunction and oxidative stress

inferredcites →https://doi.org/10.1016/j.bpa.2020.12.011openalex-snapshot

COVID-19-associated acute respiratory distress syndrome (CARDS): Current knowledge on pathophysiology and ICU treatment – A narrative review

inferredcites →https://doi.org/10.1016/j.ccc.2022.01.001openalex-snapshot

Postacute Sequelae of COVID-19 Critical Illness

inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

inferredcites →https://doi.org/10.1016/j.coph.2018.12.001openalex-snapshot

Clinical effectiveness of novel rosacea therapies

inferredcites →https://doi.org/10.1016/j.dsx.2021.102186openalex-snapshot

Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials

inferredcites →https://doi.org/10.1016/j.eclinm.2021.100959openalex-snapshot

Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial

inferredcites →https://doi.org/10.1016/j.heliyon.2021.e07311openalex-snapshot

RETRACTED: Ivermectin-functionalized multiwall carbon nanotube enhanced the locomotor activity and neuropathic pain by modulating M1/M2 macrophage and decrease oxidative stress in rat model of spinal cord injury

inferredcites →https://doi.org/10.1016/j.ijantimicag.2019.05.003openalex-snapshot

Ivermectin: From theory to clinical application

inferredcites →https://doi.org/10.1016/j.ijid.2020.11.191openalex-snapshot

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

inferredcites →https://doi.org/10.1016/j.ijid.2021.02.014openalex-snapshot

Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico

inferredcites →https://doi.org/10.1016/j.intimp.2008.12.016openalex-snapshot

Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages

inferredcites →https://doi.org/10.1016/j.micinf.2021.104806openalex-snapshot

Bacterial and fungal co-infections among COVID-19 patients in intensive care unit

inferredcites →https://doi.org/10.1016/j.nmni.2021.100915openalex-snapshot

Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known outcomes in untreated patients

inferredcites →https://doi.org/10.1016/j.pestbp.2019.06.009openalex-snapshot

Ivermectin induces apoptosis of porcine trophectoderm and uterine luminal epithelial cells through loss of mitochondrial membrane potential, mitochondrial calcium ion overload, and reactive oxygen species generation

inferredcites →https://doi.org/10.1016/j.vetpar.2016.06.015openalex-snapshot

Ivermectin exhibits potent anti-mitotic activity

inferredcites →https://doi.org/10.1016/s0014-2999(01)01321-8openalex-snapshot

Anti-inflammatory effects of macrolide antibiotics

inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

inferredcites →https://doi.org/10.1016/s0140-6736(21)00634-6openalex-snapshot

Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform

inferredcites →https://doi.org/10.1038/329752a0openalex-snapshot

Merck's new drug free to WHO for river blindness programme

inferredcites →https://doi.org/10.1038/cdd.2008.21openalex-snapshot

The role of hypoxia-inducible factors in tumorigenesis

inferredcites →https://doi.org/10.1038/nature01339openalex-snapshot

Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

inferredcites →https://doi.org/10.1038/s41368-020-0074-xopenalex-snapshot

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

inferredcites →https://doi.org/10.1038/s41392-021-00726-wopenalex-snapshot

HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19

inferredcites →https://doi.org/10.1038/s41418-020-00633-7openalex-snapshot

An aberrant STAT pathway is central to COVID-19

inferredcites →https://doi.org/10.1038/s41429-020-0336-zopenalex-snapshot

Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen

inferredcites →https://doi.org/10.1038/sj.onc.1210008openalex-snapshot

Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance

inferredcites →https://doi.org/10.1038/srep16222openalex-snapshot

Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via Ivermectin induces a non-apoptotic and inflammatory form of cancer cell death

inferredcites →https://doi.org/10.1042/bj20120150openalex-snapshot

Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus

inferredcites →https://doi.org/10.1056/nejmc2004973openalex-snapshot

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

inferredcites →https://doi.org/10.1056/nejmoa2002032openalex-snapshot

Clinical Characteristics of Coronavirus Disease 2019 in China

inferredcites →https://doi.org/10.1056/nejmoa2115869openalex-snapshot

Effect of Early Treatment with Ivermectin among Patients with Covid-19

inferredcites →https://doi.org/10.1093/brain/awv167openalex-snapshot

DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis

inferredcites →https://doi.org/10.1093/cid/ciaa1120openalex-snapshot

Bacterial Coinfection in COVID-19

inferredcites →https://doi.org/10.1093/cid/ciaa530openalex-snapshot

Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing

inferredcites →https://doi.org/10.1093/cid/ciab591openalex-snapshot

Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials

inferredcites →https://doi.org/10.1093/icb/icz136openalex-snapshot

Variation in Local and Systemic Pro-Inflammatory Immune Markers of Wild Wood Mice after Anthelmintic Treatment

inferredcites →https://doi.org/10.1093/jac/dkz524openalex-snapshot

Safety of high-dose ivermectin: a systematic review and meta-analysis

inferredcites →https://doi.org/10.1093/jtm/taab005openalex-snapshot

From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?

inferredcites →https://doi.org/10.1093/qjmed/hcab247openalex-snapshot

Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis

inferredcites →https://doi.org/10.1097/00001813-199609000-00005openalex-snapshot

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor

inferredcites →https://doi.org/10.1097/mjt.0000000000001402openalex-snapshot

Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines

inferredcites →https://doi.org/10.1099/jmm.0.001350openalex-snapshot

Co-infection in critically ill patients with COVID-19: an observational cohort study from England

inferredcites →https://doi.org/10.1111/all.13118openalex-snapshot

Topical ivermectin improves allergic skin inflammation

inferredcites →https://doi.org/10.1111/apa.15271openalex-snapshot

Why is COVID‐19 so mild in children?

inferredcites →https://doi.org/10.1111/ijcp.14818openalex-snapshot

Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019

inferredcites →https://doi.org/10.1111/j.1472-8206.2009.00684.xopenalex-snapshot

Avermectin exerts anti‐inflammatory effect by downregulating the nuclear transcription factor kappa‐B and mitogen‐activated protein kinase activation pathway

inferredcites →https://doi.org/10.1111/j.1472-8206.2010.00896.xopenalex-snapshot

Protective effect of abamectin on acute lung injury induced by lipopolysaccharide in mice

inferredcites →https://doi.org/10.1111/j.1476-5381.2012.01987.xopenalex-snapshot

Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors

inferredcites →https://doi.org/10.1124/mol.53.2.283openalex-snapshot

Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor

inferredcites →https://doi.org/10.1126/science.abd3629openalex-snapshot

A molecular pore spans the double membrane of the coronavirus replication organelle

inferredcites →https://doi.org/10.1128/aac.01696-12openalex-snapshot

Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains

inferredcites →https://doi.org/10.1136/bmj.m1091openalex-snapshot

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

inferredcites →https://doi.org/10.1136/bmj.m2980openalex-snapshot

Drug treatments for covid-19: living systematic review and network meta-analysis

inferredcites →https://doi.org/10.1136/bmj.m3379openalex-snapshot

A living WHO guideline on drugs for covid-19 (2020-2023)

inferredcites →https://doi.org/10.1136/bmjopen-2021-050532openalex-snapshot

Effectiveness and safety of ivermectin in the treatment of COVID-19: protocol for a systematic review and meta-analysis

inferredcites →https://doi.org/10.1136/openhrt-2020-001350openalex-snapshot

Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

inferredcites →https://doi.org/10.1136/postgradmedj-2020-138577openalex-snapshot

COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment

inferredcites →https://doi.org/10.1146/annurev-med-042420-110629openalex-snapshot

COVID-19 Critical Illness: A Data-Driven Review

inferredcites →https://doi.org/10.1164/rccm.201308-1483stopenalex-snapshot

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

inferredcites →https://doi.org/10.1172/jci.insight.99431openalex-snapshot

Macrophage P2X4 receptors augment bacterial killing and protect against sepsis

inferredcites →https://doi.org/10.1177/03000605211013550openalex-snapshot

Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial

inferredcites →https://doi.org/10.1177/10600280211028242openalex-snapshot

Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review

inferredcites →https://doi.org/10.1177/1087057110390360openalex-snapshot

An AlphaScreen®-Based Assay for High-Throughput Screening for Specific Inhibitors of Nuclear Import

inferredcites →https://doi.org/10.1177/11779322211025876openalex-snapshot

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins

inferredcites →https://doi.org/10.1182/blood-2010-01-262675openalex-snapshot

The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells

inferredcites →https://doi.org/10.1186/1471-2350-11-111openalex-snapshot

Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?

inferredcites →https://doi.org/10.1186/s12879-021-06104-9openalex-snapshot

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

inferredcites →https://doi.org/10.1186/s12879-021-06585-8openalex-snapshot

Clinical characteristics and risk factors of fatal patients with COVID-19: a retrospective cohort study in Wuhan, China

inferredcites →https://doi.org/10.1186/s12879-022-07589-8openalex-snapshot

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype

inferredcites →https://doi.org/10.1186/s12917-020-02612-zopenalex-snapshot

Mechanisms of ivermectin-induced wound healing

inferredcites →https://doi.org/10.1186/s13293-020-00301-yopenalex-snapshot

The impact of sex and gender on immunotherapy outcomes

inferredcites →https://doi.org/10.1186/s13756-018-0314-4openalex-snapshot

In vitro activity of ivermectin against Staphylococcus aureus clinical isolates

inferredcites →https://doi.org/10.1208/s12248-007-9000-9openalex-snapshot

The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

inferredcites →https://doi.org/10.12688/wellcomeopenres.16580.1openalex-snapshot

Ethnicity, pre-existing comorbidities, and outcomes of hospitalised patients with COVID-19

inferredcites →https://doi.org/10.1371/journal.pbio.3000715openalex-snapshot

A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis

inferredcites →https://doi.org/10.1371/journal.pone.0268667openalex-snapshot

Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients

inferredcites →https://doi.org/10.1385/jmn:30:1:107openalex-snapshot

Expression of Nicotinic Acetylcholine Receptors on Murine Alveolar Macrophages

inferredcites →https://doi.org/10.1515/hsz-2015-0171openalex-snapshot

The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways

inferredcites →https://doi.org/10.15252/emmm.202114122openalex-snapshot

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin

inferredcites →https://doi.org/10.15252/msb.20209610openalex-snapshot

The protein expression profile of ACE2 in human tissues

inferredcites →https://doi.org/10.18433/jpps31457openalex-snapshot

Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis

inferredcites →https://doi.org/10.21203/rs.3.rs-100956/v3openalex-snapshot

WITHDRAWN: Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic

inferredcites →https://doi.org/10.2174/138920112800399248openalex-snapshot

Ivermectin in Human Medicine, An Overview of the Current Status of Its Clinical Applications

inferredcites →https://doi.org/10.21873/invivo.12134openalex-snapshot

Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2

inferredcites →https://doi.org/10.2217/fvl-2020-0342openalex-snapshot

Exploring the Binding Efficacy of Ivermectin Against the Key Proteins of SARS-CoV-2 Pathogenesis: an in silico Approach

inferredcites →https://doi.org/10.2217/fvl-2021-0249openalex-snapshot

Toll-like Receptor 4 in COVID-19: Friend Or foe?

inferredcites →https://doi.org/10.31083/j.rcm.2020.04.260openalex-snapshot

Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection

inferredcites →https://doi.org/10.31546/2633-8653.1007openalex-snapshot

Study of the Efficacy and Safety of Topical Ivermectin + Iota-Carrageenan in the Prophylaxis against COVID-19 in Health Personnel

inferredcites →https://doi.org/10.3205/dgkh000370openalex-snapshot

Bacterial co-infections and antibiotic resistance in patients with COVID-19

inferredcites →https://doi.org/10.32394/rpzh.2021.0169openalex-snapshot

Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic

inferredcites →https://doi.org/10.3389/fcimb.2021.700502openalex-snapshot

Combination Treatment With Remdesivir and Ivermectin Exerts Highly Synergistic and Potent Antiviral Activity Against Murine Coronavirus Infection

inferredcites →https://doi.org/10.3389/fpubh.2020.00152openalex-snapshot

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

inferredcites →https://doi.org/10.3390/cancers12082296openalex-snapshot

Transcription Factors in Cancer Development and Therapy

inferredcites →https://doi.org/10.3390/diagnostics11091645openalex-snapshot

Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis

inferredcites →https://doi.org/10.3390/ijms22115460openalex-snapshot

Possible Beneficial Actions of Caffeine in SARS-CoV-2

inferredcites →https://doi.org/10.3390/ijms23020935openalex-snapshot

Could Lower Testosterone in Older Men Explain Higher COVID-19 Morbidity and Mortalities?

inferredcites →https://doi.org/10.3390/ijms23084167openalex-snapshot

Theophylline: Old Drug in a New Light, Application in COVID-19 through Computational Studies

inferredcites →https://doi.org/10.3390/ph13080196openalex-snapshot

Avermectin Derivatives, Pharmacokinetics, Therapeutic and Toxic Dosages, Mechanism of Action, and Their Biological Effects

inferredcites →https://doi.org/10.3390/v12040372openalex-snapshot

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

inferredcites →https://doi.org/10.37757/mr2021.v23.n3.10openalex-snapshot

Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications

inferredcites →https://doi.org/10.3892/mmr.2017.8231openalex-snapshot

Ivermectin as an inhibitor of cancer stem‑like cells

inferredcites →https://doi.org/10.3892/wasj.2021.132openalex-snapshot

Hyperbaric oxygen therapy in overweight and obese patients with COVID‑19

inferredcites →https://doi.org/10.4081/monaldi.2021.1954openalex-snapshot

Risk factors for Covid-19 in India

inferredcites →https://doi.org/10.4172/2155-9899.1000311openalex-snapshot

Macrophage Polarization in Virus-Host Interactions

inferredcites →https://doi.org/10.5021/ad.2019.31.s.s27openalex-snapshot

Perioral Dermatitis Successfully Treated with Topical Ivermectin

inferredcites →https://doi.org/10.5114/ada.2019.82825openalex-snapshot

New indications for topical ivermectin 1% cream: a case series study

inferredcites →https://doi.org/10.5603/arm.a2021.0088openalex-snapshot

Role of Ivermectin in Patients Hospitalized with COVID-19: A Systematic Review of Literature

inferredcites →https://doi.org/10.7717/peerj.10018openalex-snapshot

The utility of MEWS for predicting the mortality in the elderly adults with COVID-19: a retrospective cohort study with comparison to other predictive clinical scores

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.3897/pharmacia.71.e114753zenodo-depositor-declared

Effects of topical Ivermectin on imiquimod-induced Psoriasis in mouse model – Novel findings

inferred← citeshttps://doi.org/10.1007/978-981-95-4522-3_6openalex-snapshot

COVID-19 Management Using Drug Repurposing

inferred← citeshttps://doi.org/10.1007/s00210-025-04527-8openalex-snapshot

Global research hotspots, trends, and future directions of ivermectin research: an informatics investigation (2020–2025)

inferred← citeshttps://doi.org/10.1038/s41598-026-53626-wopenalex-snapshot

Integrated in vitro and in vivo evaluation of ivermectin hydrogel formulation for management of scabies with pharmacological assessment

inferred← citeshttps://doi.org/10.1186/s12879-023-08445-zopenalex-snapshot

Epidemiological, clinical, therapeutic features and predictors of death among COVID-19 patients hospitalized in Parakou: a cross-sectional study in Northern Benin

inferred← citeshttps://doi.org/10.20473/javest.v6.i1.2025.85-90openalex-snapshot

Effectiveness Therapy to Eliminate Parasite in Cattle at Teaching Factory Polytechnic State of Lampung

inferred← citeshttps://doi.org/10.2217/fvl-2023-0006openalex-snapshot

A Twisting Tale of Misinformation: Should Ivermectin be Approved as a Treatment for COVID-19 Disease?

inferred← citeshttps://doi.org/10.22541/au.171869648.86848921/v1openalex-snapshot

Hydroxychloroquine Induces Changes in Brain Oscillations in Electrocorticographic Records Not Concurrent with Alterations in Cardiac and Biochemical

inferred← citeshttps://doi.org/10.3390/biomed3020023openalex-snapshot

Public Health Needs the Public Trust: A Pandemic Retrospective

inferred← citeshttps://doi.org/10.3390/cimb45010028openalex-snapshot

A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors

inferred← citeshttps://doi.org/10.3390/covid6060103openalex-snapshot

Pharmacological Profiles and Recovery Predictors in Severe COVID-19

inferred← citeshttps://doi.org/10.3390/life13112121openalex-snapshot

Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response

inferred← citeshttps://doi.org/10.3390/pharmaceutics17111384openalex-snapshot

Therapeutic and Formulation Advances of Ivermectin in Veterinary and Human Medicine

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.